ICON Additional Paid-in Capital 2010-2025 | ICLR
ICON additional paid-in capital from 2010 to 2025. Additional paid-in capital can be defined as the excess over par value paid for common securities.
- ICON additional paid-in capital for the quarter ending March 31, 2025 was $7.037B, a 0.97% increase year-over-year.
- ICON additional paid-in capital for 2024 was $7.02B, a 1.12% increase from 2023.
- ICON additional paid-in capital for 2023 was $6.943B, a 1.5% increase from 2022.
- ICON additional paid-in capital for 2022 was $6.84B, a 1.58% increase from 2021.
| ICON Annual Additional Paid-in Capital (Millions of US $) |
|
|---|---|
| 2024 | $7,020 |
| 2023 | $6,943 |
| 2022 | $6,840 |
| 2021 | $6,734 |
| 2020 | $617 |
| 2019 | $578 |
| 2018 | $530 |
| 2017 | $481 |
| 2016 | $438 |
| 2015 | $383 |
| 2014 | $327 |
| 2013 | $280 |
| 2012 | $237 |
| 2011 | $212 |
| 2010 | $197 |
| 2009 | $174 |
| ICON Quarterly Additional Paid-in Capital (Millions of US $) |
|
|---|---|
| 2025-03-31 | $7,037 |
| 2024-12-31 | $7,020 |
| 2024-09-30 | $7,012 |
| 2024-06-30 | $6,989 |
| 2024-03-31 | $6,970 |
| 2023-12-31 | $6,943 |
| 2023-09-30 | $6,924 |
| 2023-06-30 | $6,891 |
| 2023-03-31 | $6,868 |
| 2022-12-31 | $6,840 |
| 2022-09-30 | $6,819 |
| 2022-06-30 | $6,787 |
| 2022-03-31 | $6,760 |
| 2021-12-31 | $6,734 |
| 2021-09-30 | $6,700 |
| 2021-06-30 | $632 |
| 2021-03-31 | $623 |
| 2020-12-31 | $617 |
| 2020-09-30 | $610 |
| 2020-06-30 | $593 |
| 2020-03-31 | $585 |
| 2019-12-31 | $578 |
| 2019-09-30 | $572 |
| 2019-06-30 | $560 |
| 2019-03-31 | $540 |
| 2018-12-31 | $530 |
| 2018-09-30 | $521 |
| 2018-06-30 | $508 |
| 2018-03-31 | $491 |
| 2017-12-31 | $481 |
| 2017-09-30 | $472 |
| 2017-06-30 | $463 |
| 2017-03-31 | $450 |
| 2016-12-31 | $438 |
| 2016-09-30 | $427 |
| 2016-06-30 | $409 |
| 2016-03-31 | $398 |
| 2015-12-31 | $383 |
| 2015-09-30 | $373 |
| 2015-06-30 | $356 |
| 2015-03-31 | $343 |
| 2014-12-31 | $327 |
| 2014-09-30 | $317 |
| 2014-06-30 | $302 |
| 2014-03-31 | $294 |
| 2013-12-31 | $280 |
| 2013-09-30 | $266 |
| 2013-06-30 | $253 |
| 2013-03-31 | $245 |
| 2012-12-31 | $237 |
| 2012-09-30 | $226 |
| 2012-06-30 | $221 |
| 2012-03-31 | $215 |
| 2011-12-31 | $212 |
| 2011-09-30 | $207 |
| 2011-06-30 | $204 |
| 2011-03-31 | $200 |
| 2010-12-31 | $197 |
| 2010-09-30 | $193 |
| 2010-06-30 | $189 |
| 2010-03-31 | $182 |
| 2009-12-31 | $174 |
| 2009-09-30 | $168 |
| 2009-06-30 | $166 |
| 2009-03-31 | $164 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $11.324B | $8.282B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $143.728B | 26.96 |
| Elevance Health (ELV) | United States | $94.145B | 12.15 |
| CVS Health (CVS) | United States | $81.986B | 10.19 |
| Cencora (COR) | United States | $53.983B | 18.77 |
| Natera (NTRA) | United States | $21.477B | 0.00 |
| DiDi Global (DIDIY) | China | $21.462B | 32.57 |
| BioMerieux (BMXMF) | France | $15.263B | 0.00 |
| Solventum (SOLV) | United States | $12.941B | 13.70 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.036B | 0.00 |
| Revvity (RVTY) | United States | $11.610B | 19.98 |
| Doximity (DOCS) | United States | $11.396B | 59.26 |
| CochLear (CHEOY) | Australia | $11.195B | 0.00 |
| Viatris (VTRS) | United States | $10.516B | 3.61 |
| Medpace Holdings (MEDP) | United States | $9.017B | 23.95 |
| Avantor (AVTR) | United States | $8.859B | 12.87 |
| HealthEquity (HQY) | United States | $8.361B | 41.13 |
| Sonic Healthcare (SKHHY) | Australia | $8.215B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.027B | 13.77 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| Bausch + Lomb (BLCO) | Canada | $4.202B | 24.77 |
| BrightSpring Health Services (BTSG) | United States | $3.894B | 36.05 |
| Sotera Health (SHC) | United States | $3.832B | 21.77 |
| Surgery Partners (SGRY) | United States | $2.982B | 38.77 |
| Alignment Healthcare (ALHC) | United States | $2.952B | 0.00 |
| Concentras Parent (CON) | United States | $2.771B | 16.01 |
| Organon (OGN) | United States | $2.264B | 2.41 |
| Ardent Health Partners (ARDT) | United States | $2.121B | 9.04 |
| Premier (PINC) | United States | $2.101B | 14.38 |
| Progyny (PGNY) | United States | $1.886B | 41.51 |
| PACS (PACS) | United States | $1.698B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.683B | 64.83 |
| GoodRx Holdings (GDRX) | United States | $1.669B | 31.07 |
| Teladoc Health (TDOC) | United States | $1.289B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.234B | 9.39 |
| Agilon Health (AGL) | United States | $1.229B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.000B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.911B | 14.23 |
| AMN Healthcare Services Inc (AMN) | United States | $0.866B | 8.11 |
| Embecta (EMBC) | United States | $0.725B | 4.89 |
| QDM (QDMI) | Hong Kong, SAR China | $0.690B | 0.00 |
| Nutex Health (NUTX) | United States | $0.689B | 13.50 |
| Enhabit (EHAB) | United States | $0.530B | 43.58 |
| InnovAge Holding (INNV) | United States | $0.513B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.513B | 13.59 |
| Sonida Senior Living (SNDA) | United States | $0.512B | 0.00 |
| LifeMD (LFMD) | United States | $0.389B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.363B | 0.00 |
| SBC Medicals (SBC) | United States | $0.359B | 0.00 |
| Beauty Health (SKIN) | United States | $0.220B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.202B | 0.00 |
| Oncology Institute (TOI) | United States | $0.193B | 0.00 |
| DocGo (DCGO) | United States | $0.147B | 24.08 |
| Sera Prognostics (SERA) | United States | $0.087B | 0.00 |
| So-Young (SY) | China | $0.087B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.087B | 0.00 |
| KindlyMD (KDLY) | United States | $0.082B | 0.00 |
| OncoCyte (OCX) | United States | $0.080B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.076B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
| Biodesix (BDSX) | United States | $0.053B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.031B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| ModivCare (MODV) | United States | $0.018B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |